Company Filing History:
Years Active: 2001-2006
Title: Kevin D Walker: Innovator in Paclitaxel Biosynthesis
Introduction
Kevin D Walker is a notable inventor based in Pullman, WA (US). He has made significant contributions to the field of biochemistry, particularly in the biosynthesis of paclitaxel, a vital compound used in cancer treatment. With a total of 3 patents, Walker's work has advanced the understanding and production of important taxoids.
Latest Patents
Walker’s latest patents include groundbreaking discoveries in the transacylases of the paclitaxel biosynthetic pathway. His first patent discloses transacylase enzymes and their application in producing paclitaxel and related taxoids, as well as intermediates in the biosynthetic pathway. Additionally, he has developed nucleic acid sequences that encode these transacylase enzymes. Another significant patent focuses on the nucleic acid molecules encoding 10-deacetylbaccatin III-O-acetyl transferase and related products. This patent details the use of specific enzymes, such as taxadienol 5-O-acetyl transacylase (TAX1) and 10-deacetylbaccatin III-10-O-acetyl transferase (TAX6), in the production of Taxol™ and its intermediates.
Career Highlights
Kevin D Walker is affiliated with Washington State University, where he conducts research and develops innovative solutions in his field. His work has not only contributed to academic knowledge but has also had practical implications in the pharmaceutical industry.
Collaborations
Walker has collaborated with esteemed colleagues, including Rodney Bruce Croteau and Anne Schoendorf, to further enhance the research and development of paclitaxel biosynthesis.
Conclusion
Kevin D Walker's contributions to the field of biochemistry, particularly in the biosynthesis of paclitaxel, highlight his role as an influential inventor. His patents and collaborations continue to pave the way for advancements in cancer treatment.